EZH2 and pancreatic neoplasm: Bao et al. demonstrated that a novel curcumin analog CDF inhibited pancreatic tumor growth and aggressiveness through upregulating a panel of tumor suppressive miRNAs let-7, miR-26a, miR-101 and attenuating EZH2 expression [28].